Overview
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Phase III long-term safety study of Effexor XR in patients with major depression.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of PfizerTreatments:
Venlafaxine Hydrochloride
Criteria
Inclusion Criteria:- Patients who complete the Phase III double-blind study (Protocol Number 0600B1-816)
Exclusion Criteria:
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder